Metformin Wockhardt Uk (Metformin Hydrochloride)

Metformin works primarily by activating AMP‑activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis, reduces intestinal glucose absorption, and enhances peripheral insulin sensitivity. These combined actions lower circulating glucose without increasing insulin secretion.

The appropriate dose of Metformin Wockhardt UK is determined by the prescribing healthcare professional based on the individual’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Metformin may be used during pregnancy when the benefits outweigh potential risks, such as in gestational diabetes, but this decision must be made by a qualified obstetrician. Limited data are available for breastfeeding; the prescriber should evaluate the risk‑benefit profile for each patient.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin belongs to the biguanide class and is often preferred as first‑line therapy because it does not cause weight gain and has a low risk of hypoglycaemia compared with sulfonylureas or insulin. Unlike newer agents such as SGLT2 inhibitors, it does not increase urinary glucose excretion.

Metformin Wockhardt UK should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Metformin Wockhardt UK is taken orally, usually with meals to minimise gastrointestinal upset. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or during major surgery. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those receiving certain contrast imaging procedures without appropriate renal monitoring.